Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human immune therapies using a CD27 agonist alone or in combination with other immune modulators

Human immune therapies using a CD27 agonist alone or in combination with other immune modulators

US Patent 8481029 · Granted Jul 9, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer and B-cell related disease therapy2025
Cancer and B-cell related disease therapy2025
Immunomodulatory antibodies2023
Immunomodulatory antibodies2023
Combined use of FcγRIIb (CD32B) and CD20 specific antibodies2023
Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody2022
Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody2022
Modified antibodies containing modified IGG2 domains which elicit agonist or ant2021
Immunomodulatory antibodies2021
Immunomodulatory antibodies2021
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies2020
Human immune therapies using a CD27 agonist in combination with another immune a2018